appointments

News

Lykos CEO steps down after MDMA is rejected by FDA

The fallout from the FDA's recent decision not to approve Lykos Therapeutics' psychedelic treatment has spread to its senior management, with chief executive Amy Emerson stepping down.

R&D

Changing Faces: Pharma and biotech hires for August 2024

Welcome to the August edition of Changing Faces for the pharma and biotech sectors.

Market Access

Changing Faces – Board of Directors appointments from July 2...

Welcome back to Changing Faces for the month of July. We’re trying something new this month.

Sales & Marketing

female shaking hands with another person

Changing Faces – Agency, consultancy, and investor hires fro...

Welcome back to Changing Faces for the month of July.

Digital

Changing Faces – Digital and supplier hires from July 2024

Welcome back to Changing Faces for the month of July. Today we’re looking at CROs, CDMOs, suppliers, and tech vendors – the industry around pharma that keeps pharma ticking.

News

BioMarin's new hires Greg Friberg (l) and James Sabry (r)

BioMarin revamps leadership with ex-Roche, Amgen execs

BioMarin Pharmaceutical has made a couple of appointments aimed at boosting its pipeline, both internally and externally, with C-suite appointments in charge of R&D and business develop